SPRINGFIELD, MO (PRWEB) April 01, 2015
North Americas premier refrigerated, flatbed and tanker trucking company Prime, Inc. announced at the Mid America Trucking Show (MATS) that they will host its third annual Fittest of the Fleet competition on Saturday, August 29, 2015 at Prime headquarters in Springfield, MO.
The annual fitness competition was created by Siphiwe Baleka, Primes Driver Health and Fitness Coach, to showcase drivers who have made fitness a daily part of their truck driving career. Baleka, who conducted a MATS seminar on The Future of Driver Health and Fitness, issued a personal invitation and challenge to other fleets to send their most fit male and female truck drivers to this years competition.
There is an obesity epidemic leading to premature death in the trucking industry and as a consequence, helping drivers lose weight has grown in popularity, says Baleka. There are weight loss competitions for drivers, but nothing to showcase those drivers who are managing to maintain very high levels of fitness while living on the road. This competition is designed to identify who is the fittest truck driver in America.
Rodney McCloud and Justin Boschee, the winner and third place finisher of the 2013 Fittest of the Fleet competition, were featured in the April 2014 issue of Mens Health Magazine. In 2014, Peterbilt sponsored the competition and put up prize money, which was claimed by twenty-seven year old Randee Lewis. In 2015, the goal is to make it a truly national competition.
We are reserving 30 competition slots for drivers from other fleets across America. We can do a lot to promote both driver image and fitness by exhibiting those truck drivers who are in peak physical condition, says Baleka. What fleet wouldnt be proud to boast it has the fittest truck driver in America?
For more information about the competition, including eligibility and online registration, visit driverhealthandfitness.com/dhf-athletic-division/fittest-driver-at-prime/ or contact Siphiwe Baleka at sbaleka(at)primeinc(dot)com
About Prime Inc.
Founded in 1970 by Robert Low, Prime, Inc. is North Americas most successful refrigerated, flatbed, tanker and logistics trucking company. Headquartered in Springfield, MO, Prime’s personnel, equipment and technology remains on the cutting edge of the transportation industry, and the company’s growth remains steady and well managed.
San Francisco, CA (PRWEB) October 07, 2011
Advanced Male Medical Center exclusively specializes in and is dedicated to removing the difficulties that keep men from experiencing a healthy and active sex life. As part of their program, which guarantees results, the center uses all FDA approved medications. Men of all ages using medications or who have medical-related male impotence problems can be treated in just one visit. Each of their California-licensed physicians is an erectile dysfunction specialist and they specialize in the treatment of erectile dysfunction and premature ejaculation. Their physicians will carefully test and diagnose each patients specific concerns, then set up a program to treat the patients problem.
On October 19th, San Francisco erectile dysfunction center, Advanced Male Medical Center, in partnership with The San Francisco Examiner and the San Francisco Senior Center, will be offering a free class to learn about the effects of low testosterone in men and women with Dr. Nick Shah, M.D., graduate of the John Hopkins School of Medicine, as the speaker.
The class will be held at the San Francisco Senior Center at 481 O’Farrel Street from 5:30 p.m. to 7:30 p.m., said Larry Stephens of Advanced Male Medical Center. Please call (415) 9233-4490 to reserve a spot. Additionally those who attend will automatically be entered to win a trip for two including airfare and hotel.
Advanced Male Medical Center’s San Francisco male impotence doctors treat each and every patients sexual needs and physical desires on an individual basis. Because they are dedicated solely to this medical condition of male impotence, they far exceed what an average doctor visit may be able to offer. Their trained medical staff has been treating patients with erectile dysfunction and premature ejaculation for more than 10 years, and they understand the intense need for help and to provide answers about a common and treatable condition.
They are conveniently located in San Francisco just off the Embarcadero across from Pier 31 at 1700 Montgomery Street, Suite 215. They provide a dignified, professional service to each and every patient who visits the clinic. Their staff includes doctors who specialize in treating medical-related male impotence conditions and male counselors are standing by to meet every patients needs.
For more information on pre-mature ejaculation from San Franciscos Advanced Male Medical Center and their services, give them a call at (415) 868-4899 or visit them on the web at http://www.advancedmalemedical.com. They are located at 1700 Montgomery St. Ste. 215 San Francisco CA 94111.
About Advanced Male Medical Center
Advanced Male Medical Center is a dedicated medical clinic devoted to the needs of men facing Erectile Dysfunction (ED) and Premature Ejaculation (PE). They specialize in treating men that are looking for personal help and that have tried other resources such as oral medications (Viagra
Pair charged with stealing, selling erectile dysfunction medication
CLEVELAND, Ohio — A man and a woman were charged in federal court Friday with stealing prescription erectile dysfunction medication from a pharmacy at the Cleveland Clinic and illegally selling it out of a store in East Cleveland. Zacresha Johnson, 39 …
Read more on cleveland.com
Regenerative Medicine Using Liposuction Byproduct May Lead To Erectile …
Following prostate cancer treatment, many men experience erectile dysfunction for the first time. Though half will return to normal function within a year, a new animal study investigating two regenerative medicine techniques offers hope to those whose …
Read more on Medical Daily
Finasteride's Sexual Dysfunction Side Effects Poorly Reported In Male Baldness …
Out of 34 clinical trials reviewed on the popular hair loss drug finasteride, zero were found to properly relay safety information on the drug's controversial side effect of sexual dysfunction. Researchers from Northwestern University's Feinberg School …
Read more on Medical Daily
Baltimore, MD (PRWEB) March 29, 2015
While we are celebrating International Womens month, many will spend the month with other women supporting and enjoying The Pink Event
San Francisco, CA (PRWEB) December 21, 2011
More than one third of men over 60 have erectile dysfunction. Medications play a role in causing ED, and a current study describes drugs most commonly linked with a higher risk for ED.
Diana C. Londo
'Not a super-fix': The hard facts about effects of Viagra exposed in Man Uni study
Is your sex life suffering because you can no longer get it up? Is a night in with the missus just not what it used to be? Well, you may be no spring chicken but you can put a spring back in your step by popping this little blue pill. Viagra – it will …
Read more on Mancunian Matters
Heartbroken mum reveals how doctors used Viagra in desperate bid to save her …
Desperate doctors used Viagra as they battled to save the life a dying three-week-old baby, born with a serious heart condition. Lewis McKain's parents Cheryl and Joe had already said their goodbyes when medics told her that injecting the drug into the …
Read more on mirror.co.uk
BETHLEHEM, Pa (PRWEB) October 15, 2014
Illini Precast (illiniprecast.com), Westchester, Ill., has joined AltusGroup (altusprecast.com) to market CarbonCast Double Tees in the Upper Midwest. Illini Precast is the fifth precast manufacturer to join AltusGroup in the past 20 months and brings the total number of North American precasters in the organization to 18, an all-time high.
Illini Precast will manufacture CarbonCast Double Tees in its Marseilles, Ill., and Burlington, Wis., locations for parking structures across Northern Illinois, Wisconsin, Indiana, and Michigan. The CarbonCast license and AltusGroup membership will give them additional technical capability and product line expansion to meet the demanding needs of the region and the parking industry noted Craig Wagenbach, Illini Precast President.
Coincidentally, the Burlington, Wis., plant was the first precast plant in world to fabricate CarbonCast Double Tees for a commercial application. The facility, which at the time was owned by J.W. Peters, produced CarbonCast Double Tees for the top level of a parking structure in Wisconsin. The garage is still in operation.
CarbonCast Double Tees use C-GRID carbon fiber grid as a replacement for welded wire mesh in double tee flanges. The non-corrosive nature of C-GRID reduces the amount of concrete cover thats necessary to protect the reinforcing. As a result, CarbonCast Double Tee flanges can be thinned to 3-1/2, reducing a tees weight by 8 percent. Additionally, they eliminate the need for corrosion inhibitors and sealers upon commissioning and throughout the life of the garage.
Illini Precast and its co-owned company, KW Precast, have more than 40 years of experience in the precast industry. They specialize in precast parking-structures for health care, commercial, residential and municipalities, as well as precast bridge beams. Illini Precast is an integrated supplier of precast parking structures offering precast columns, beams, double tees, wall panels, stairs, sealer-sealant, pour strips, and erection.
Illini Precast and KW Precast have built their reputations on the parking garage market. The addition of CarbonCast Double Tees to their product offerings will strengthen their position as innovative, market-leading companies, said John Carson, executive director of AltusGroup. CarbonCast Double Tees should be particularly appealing to garage owners in the upper Midwest, where salt from roads during the winter months can damage the driving surface of parking structures. Non-corrosive C-GRID reinforcing in the flanges eliminates the possibility of corrosion there.
AltusGroup precast concrete manufacturers have installed more than 30 million square feet of CarbonCast surface area on over 700 structures since introducing the technology in 2004.
The first-ever national partnership of precast companies, AltusGroup was founded in 2003 to develop, manufacture and market precast innovations such as the award-winning CarbonCast
New York City, New York (PRWEB) October 14, 2014 (PRWEB) October 21, 2014
Turnkey Office Space, a leading NYC online search service for businesses in need of office space, weighed in on the recent conversation within the commercial real estate industry on the future of office development in Midtown Manhattan in the heart of New York City.
A recent article in The Real Deal titled Big tests ahead of de Blasio by staff reporter Adam Pincus outlines the problems New York City Mayor Bill de Blasio currently faces with future real estate development. The article cites that a significant divide has developed within the industry concerning how Mayor de Blasio should approach aging Midtown Manhattan buildings: refurbish existing structures or replace them with state-of-the-art office-space buildings.
As an advocate for environmentally-friendly building practices, Turnkey Office Space supports Mayor de Blasio in his efforts for neighborhood development of newer, greener building space, but believes all attempts should be made to refurbish older, legacy buildings.
The commercial real estate plan for Midtown Manhattan should be handled on a case-by-case basis, explained Edward Klaynberg, Managing Partner of Turnkey Office Space. City real estate developers should refurbish and reuse existing buildings that add character to and enhance neighborhoods. They can build newer and greener cost-efficient structures where opportunity for improvement exists.
Many commercial real estate investors fear that refurbishing New Yorks existing office buildings will make the city obsolete compared to international cities like London. Over the last decade, the city of London has erected several new buildings that have attracted companies around the world: the Shard, the Cheese Grater, the Walkie-Talkie and the Gherkin of Londons financial district.
Klaynberg believes the decision by Mayor de Blasio will set the tone for the types of businesses that New York Citys commercial real estate will attract. The building of new office space will result in rising rental rates, which will push smaller start-ups out of the city. And, should the international investors choose a different city to grow their business, it will leave New York City with Class A buildings and rental prices in a recovering U.S. economy. He believes the city should push for a mix of refurbished building and new buildings that will support a range of businesses at varying economic stages.
We continue to see that foreign investors dominate the acquisition market and they want newly-outfitted skyscrapers, said Klaynberg. Start-up tech companies on the other hand are challenging the office space norm. Look at Facebook for example; a successful company with a unique, single-story space. The style of buildings within a city really determines who will be occupying them.
About Turnkey Office Space:
Turnkey Office Space is a countrywide search and consulting services for companies seeking office space. They specialize in office suites, virtual offices, and co-working spaces. Turnkey can be reached via their website http://www.turnkeyofficespace.com and by phone at 1-888-282-8555.
New York, New York (PRWEB) January 14, 2015
As thousands of transvaginal mesh lawsuits (http://www.vaginalmeshlawsuit2015.com/) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that dozens of similar claims have reportedly been settled in Canada. According to CTV.com, about 35 Canadian women have resolved their cases, all of which were filed after the plaintiffs allegedly experienced pain and internal damage following mesh surgery to treat stress urinary incontinence or pelvic organ prolapse. While the companies involved and the amounts of the vaginal mesh settlements have not been disclosed, Canadian attorneys are calling the accords a victory for the thousands of women who allegedly experienced similar transvaginal mesh complications.*
Our Firm is currently representing hundreds of women in U.S. courts who allegedly experienced many of the same complications cited in the Canadian vaginal mesh lawsuits. We are encouraged by this news, and will continue to monitor these developments closely, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate legal claims on behalf of women who suffered mesh erosion, pain during sexual intercourse, organ damage, and other serious complications allegedly associated with the implantation of transvaginal mesh devices.
Vaginal Mesh Litigations
Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is an active member of the Plaintiffs Steering Committee in seven vaginal mesh litigations now underway in U.S. District Court, Southern District of West Virginia, where court records indicate more than 67,000 claims have been filed. These proceedings include: In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation – MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation – MDL No. 2326; In Re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation – MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2440; In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2187; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation – MDL No. 2327; and In Re: Neomedic Pelvic Repair System Products Liability Litigation – MDL No. 2511.
In recent months, a number of trials have concluded in the federal transvaginal mesh litigations underway in the Southern District of West Virginia. On November 20, 2014, a jury hearing a claim filed against Boston Scientific awarded the plaintiffs a total of $ 18.5 million, including $ 4 million in punitive damages, after finding that the company did not provide sufficient warnings about risks associated with its Obtryx bladder sling . (Tyree v. Boston Scientific Corp., No. 12-cv-8633). A week prior, a jury hearing a case involving Boston Scientifics Pinnacle Pelvic Floor Repair Kit awarded more than $ 26 million to four women who were injured by that device. (Enhnayem, et al. v. Boston Scientific Corp., No. 2:13-7965)
In September 2014, the federal Ethicon litigations second bellwether case concluded with an award of $ 3.27 million to a woman who suffered serious vaginal mesh complications due to the erosion of the Ethicon TVT-O Mesh sling. (Huskey v. Ethicon, Inc. et al, Case No. No. 2:2012cv05201)
The first federal trial of a C.R. Bard transvaginal mesh lawsuit concluded in the Southern District of West Virginia in August 2013, with the plaintiff being awarded $ 2 million for injuries caused by the companys Avaulta mesh product.(Cisson v. C.R. Bard Inc., 11-cv-00195, U.S. District Court)
In addition to his work on the federal mesh litigations, Bernstein Liebhard LLP Partner, Jeffrey S. Grand, was also appointed Co-Liaison Counsel in two consolidated proceedings established for C.R. Bard and Ethicon mesh lawsuits in New Jersey Superior Court. In addition, he served as a member of the plaintiffs trial team for the states first Ethicon trial, which ended in March 2013 with an $ 11 million verdict for a woman who experienced vaginal mesh complications related to the Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who allegedly suffered serious complications due to the implantation of transvaginal mesh may be entitled to receive compensation for lost wages, medical bills, pain and suffering, as well as other injury-related damages. Learn more about filing a vaginal mesh lawsuit by visiting Bernstein Liebhard LLPs website, or via the Firms Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*ctvnews.ca/health/lawsuits-being-settled-in-surgical-mesh-complications-1.2187488, CTV News, January 13, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
New York, NY (PRWEB) March 24, 2015
Adding two non-invasive imaging tests to traditional cardiovascular disease risk factor assessment more precisely predicts a healthy patients future risk of heart attack, stroke, or premature death, according to a study led by Icahn School of Medicine at Mount Sinai and published in the March 24 edition of the Journal of the American College of Cardiology(JACC).
Using imaging tests to detect disease in carotid or coronary arteries before it causes symptoms can better identify healthy individuals at increased risk than our current, traditional risk assessment methods, says the studys principal investigator Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital.
Study patients were assessed using traditional cardiovascular disease risk factor assessments for high blood pressure, abnormal cholesterol, diabetes, sedentary lifestyle, obesity, and smoking, and then additionally received two imaging tests: novel 3D vascular ultrasound and coronary artery calcium score via a low-dose computed tomography scan. Adding the two imaging tests resulted in the identification of subclinical atherosclerosis in 60 percent of the seemingly healthy study participants presenting with no clinical manifestations.
The BioImage Study was launched to identify new ways to identify subclinical cardiovascular disease before symptoms arise to help curb the growing public health and economic concern of cardiovascular disease. For three years the project followed nearly 6,000 healthy men (ages 55 to 80 years) and women (60 to 88 years) with no history or symptoms of cardiovascular disease.
Novel 3D vascular ultrasound imaging technology allowed researchers to quantify the amount of carotid artery plaque burden lining each patients carotid arteries in their neck, while a coronary artery calcium score CT scan allowed for the identification of any narrowing or hardening of the coronary arteries due to the buildup of fatty cholesterol and calcified plaque. Having increased prevalence of carotid plaque burden or coronary artery calcium are signs of atherosclerosis or diseased arteries. Only these imaging procedures could reveal this information in the healthy study participants.
The study shows those apparently healthy individuals identified with increased carotid plaque burden and coronary artery calcium were two to three times more likely to have an adverse event such as an artery blockage, or a piece of plaque becoming loose causing a heart attack or stroke. In fact, after follow-up (2.5 to 3.1 years), there were a total of 216 adverse events reported among study participants including 108 deaths, of which 27 were cardiovascular, plus 34 heart attacks, 30 strokes, 18 experienced unstable angina and hospitalized, and 79 needed revascularization procedures. Over the study duration the incidence of adverse events among those with the greatest amount of carotid and coronary atherosclerosis was 4.2 percent, approximately 8-fold higher compared to individuals with minimal disease in either vascular territory.
Our study shows the significant impact of adding carotid plaque measurement using vascular ultrasound and coronary calcium scoring with CT scan to our conventional assessment for cardiovascular disease, says Roxana Mehran, MD, the studys co-lead author and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai Heart at Icahn School of Medicine at Mount Sinai. Healthy patients with elevated calcium and plaque burden are at increased risk of experiencing adverse cardiovascular events in even a short period of just three years.
We must work to identify these patients at risk early and prevent their disease from advancing, says co-lead author Usman Baber, MD, Assistant Professor of Medicine, Cardiology, at Icahn School of Medicine at Mount Sinai. Assessing a patients risk of atherosclerosis with carotid vascular ultrasound and cardiac calcium CT imaging yields incremental gains over classical risk factors in cardiovascular risk prediction.
Using only traditional risk factor assessment for cardiovascular disease may imprecisely classify a patients risk, says Dr. Fuster. Our study shows simply adding one of our available cardiac imaging resources may more accurately predict a patients risk or diagnose their disease, also giving us an opportunity to prevent them from experiencing a future cardiac event and possibly save more lives from the burdens of cardiovascular diseases.
Dr. Fuster adds: For our patients lives and for the health of our global economies we need to improve our predictive measures for cardiovascular disease and can no longer just rely on traditional risk factors. Our results prove adding imaging-based biomarkers that directly quantify atherosclerosis are ideal adjuncts to the current conventional CVD risk factors and these imaging biomarkers may be a true game-changer to our practice of cardiovascular medicine.
According to researchers, their future research will analyze the cost-effectiveness of a new strategy of incorporating these non-invasive imaging tools into future prevention and diagnostic protocols for cardiovascular disease and to better define their use.
This study is a collaboration between Icahn School of Medicine at Mount Sinai; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; BG Medicine Inc., Waltham, Massachusetts; Montefiore Medical Center, New York; London School of Hygiene and Tropical Medicine, London, UK; and Aarhus University Hospital, Skejby, Aarhus N, in Denmark.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient servicesfrom community based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12 minority owned free standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.
For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.